Evidence map›Paper›PMID 38057343›Full record

ArticleScientific reports2023

A novel invasive Streptococcus pyogenes variant sublineage derived through recombinational replacement of the emm12 genomic region.

Yvette Unoarumhi, Morgan L Davis, Lori A Rowe, Saundra Mathis, Zhongya Li, Sopio Chochua, Yuan Li, Lesley McGee, Benjamin J Metcalf, Justin S Lee and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Molecular characterization ofMicrobial genomics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yvette UnoarumhiCenters for Disease Control and Prevention, Biotechnology Core Facility Branch, National Center for Emerging and Zoonotic Infectious Diseases, Division Scientific Resources, Atlanta, GA, USA.
Morgan L DavisCenters for Disease Control and Prevention, Biotechnology Core Facility Branch, National Center for Emerging and Zoonotic Infectious Diseases, Division Scientific Resources, Atlanta, GA, USA.
Lori A RoweCenters for Disease Control and Prevention, Biotechnology Core Facility Branch, National Center for Emerging and Zoonotic Infectious Diseases, Division Scientific Resources, Atlanta, GA, USA.
Saundra MathisCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Zhongya LiCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Sopio ChochuaCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Yuan LiCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Lesley McGeeCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Benjamin J MetcalfCenters for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA.
Justin S LeeCenters for Disease Control and Prevention, Biotechnology Core Facility Branch, National Center for Emerging and Zoonotic Infectious Diseases, Division Scientific Resources, Atlanta, GA, USA.
Bernard Beall *Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Respiratory Diseases Branch, Atlanta, GA, USA. bbeall@cdc.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group A streptococcal strains potentially acquire new M protein gene types through genetic recombination (emm switching). To detect such variants, we screened 12,596 invasive GAS genomes for strains of differing emm types that shared the same multilocus sequence type (ST). Through this screening we detected a variant consisting of 16 serum opacity factor (SOF)-positive, emm pattern E, emm82 isolates that were ST36, previously only associated with SOF-negative, emm pattern A, emm12. The 16 emm82/ST36 isolates were closely interrelated (pairwise SNP distance of 0-43), and shared the same emm82-containing recombinational fragment. emm82/ST36 isolates carried the sof12 structural gene, however the sof12 indel characteristic of emm12 strains was corrected to confer the SOF-positive phenotype. Five independent emm82/ST36 invasive case isolates comprised two sets of genetically indistinguishable strains. The emm82/ST36 isolates were primarily macrolide resistant (12/16 isolates), displayed at least 4 different core genomic arrangements, and carried 11 different combinations of virulence and resistance determinants. Phylogenetic analysis revealed that emm82/ST36 was within a minor (non-clade 1) portion of ST36 that featured almost all ST36 antibiotic resistance. This work documents emergence of a rapidly diversifying variant that is the first confirmed example of an emm pattern A strain switched to a pattern E strain.

Indexed as

Streptococcal InfectionsStreptococcus pyogenesAnti-Bacterial AgentsAntigens, BacterialBacterial Outer Membrane ProteinsDrug Resistance, BacterialGenomicsGenotypeHumansPhylogenyAnti-Bacterial AgentsAntigens, BacterialBacterial Outer Membrane Proteins

Identifiers

PMID38057343
PMCPMC10700362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.